Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Equity Brief: Ratings Changes for October 23rd: SVU, T, TDG, TOO, TSS, TXN, UAL, VASC, VNO


Print article Print article
Copyright © Thomson Reuters 2012. All rights reserved.
2012-10-23 16:26:49 -

A number of stocks were upgraded and downgraded by equities research analysts
today, as reported by Analyst Ratings Network ( bit.ly/equitybriefdaily)
and Equity Brief:

Standpoint Research downgraded shares of Supervalu (SVU) from a buy rating to a
hold rating.

Credit Suisse initiated coverage on shares of AT&T Inc. (T). They issued an
outperform rating on the stock and set a $36.50 price target. They wrote, "We
are assuming coverage of AT&T. We maintain our estimates, target price and our
Outperform rating. We believe AT&T and Verizon will continue to report solid
results for 2H12, with wireless churn continuing to improve y/y and margins
significantly better. We don't think 3Q12 results will be a major catalyst -
investors are aware of the 3Q12 iPhone launch. We think full 2H12 results will
provide proof 
for our thesis - upgrades will fall y/y in 2H12 (although likely higher in 3Q given the iPhone), contrary to expectations, and margins will be better. We will be watching these data points closely when T reports its 3Q12 results on Weds, as improvement in these data points (e.g., churn, upgrades) remains at the core of our overweight thesis." Morgan Stanley initiated coverage on shares of Transdigm Group (TDG). They issued an underweight rating on the stock. They wrote, "TDG has a solid track record of generating growth through acquisitions, but with shares up over 50%YTD, we do not think the current valuation reflects the impending slowdown in revenue growth, modest returns on capital and potential margin pressure. . TDG's management team has done an excellent job over the past several years executing on its growth-through-acquisitions strategy, but at >4x Net debt/EBITDA, greater competition for acquisitions, and an increasingly large revenue base, it will be difficult for TDG to sustain recent growth trends through acquisitions. With the stock trading at 20.2x F13e, near all-time highs on both an absolute basis and relative to peers, TDG appears priced for perfection." JPMorgan Chase upgraded shares of Teekay Offshore Part (TOO) from a neutral rating to an overweight rating. They wrote, "Our upgrade to an Overweight recommendation reflects an updated accounting of likely fleet growth over the next 18 months resulting in accelerated average DPU growth (2013e 6% vs. previous 1%) and a likely continuation of a narrowing discount to the Alerian MLP index (current 8.4% '13e yield, 6.7% at our target vs. Alerian 6.1%). Our upgraded PT (+6%) implies c.30% upside potential." - Raymond James reiterated its market perform rating on shares of Total System Services, Inc. (TSS). Gabelli downgraded shares of Texas Instruments (TXN) from a buy rating to a hold rating. Buckingham Research initiated coverage on shares of United Continental (UAL). They issued a buy rating on the stock. Feltl & Co. raised its price target on shares of Vascular Solutions Inc (VASC) from $15.25 to $16.25. They have a buy rating on the stock. They wrote, "Vascular Solutions represents a unique type of company in the market in which it operates. While none of its over 60 products are likely to be home runs within the vascular space, the company consistently hits singles and doubles with many niche products that do not see much, if any, competition from larger (or smaller) players. We believe the company has proven that it is able to execute on its strategy of continuously developing, distributing, or acquiring products with which to leverage its sales force. They currently plan on introducing about ten products per year and believe that their current sales force can drive at least $1.5 million per employee per year (up from the present ~$1.0 million run rate). With 30 products in their current development pipeline and additional opportunities for tuck-in acquisitions and distribution agreements, we believe the company will be able to drive low-teens top-line growth for the next several years. As this occurs, the company will drive operating leverage and we estimate that Vascular Solutions will be able to grow EPS at approximately double their revenue growth rate for the foreseeable future." Barclays Capital reiterated its overweight rating on shares of Vornado Realty Trust (VNO). They have a $89.00 price target on the stock. Jefferies Group downgraded shares of Ventas (VTR) from a buy rating to a hold rating. Their analysts now have a $66.00 price target on the stock. They noted that the move was a valuation call. They noted that the move was a valuation call. Stay on top of analysts' coverage with Analyst Ratings Network's free daily email newsletter that provides a concise list of analysts' upgrades, downgrades and initiations. Register at bit.ly/equitybriefdaily Content and Media Contact: newseditor@equitybrief.net This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Equity Brief via Thomson Reuters ONE [HUG#1651623]


Press Information:




Contact Person:


Disclaimer: © 2013 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser